A Study of Radiologically Evident Treatment Effects in Subjects with Glioblastoma Multiforme (GBM)
Study of Treatment Effects in Subjects with Glioblastoma Multiforme (GBM) - Glioma, Brain Tumor
Sponsor: AbbVie
Enrolling: Male and Female Patients
IRB Number: AAAR1373
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information: New data from the study of ABT-414 and ABBV-221 in patients with recurrent glioblastoma multiforme (GBM) have shown several examples where it seems evidence of disease progression (cancer that continues to grow and spread) was seen in MRI images, but examination of surgically removed tissue under the microscope did not agree with the MRI.
This study is closed
Investigator
Andrew Lassman, MD
Do You Qualify?
Have you been diagnosed with glioblastoma? Yes No
Have you been previously treated in an ABT-414 or ABBV-221 clinical trial? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Research Nurse Navigator
cancerclinicaltrials@cumc.columbia.edu
212-342-5162
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE